GeoVax Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines
August 13, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Aug. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer,...
GeoVax Reports 2020 Second Quarter Financial Results and Provides Corporate Update
August 10, 2020 09:00 ET
|
GeoVax, Inc.
Company Demonstrated Progress on COVID-19 Vaccine Development;Continued Progress in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via...
GeoVax Announces Closing of $1 Million Private Placement
June 29, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, June 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GeoVax to Participate in International Webinar Focused on the State of COVID-19 Vaccines
June 29, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, June 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GeoVax to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research
June 10, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, June 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GeoVax Labs, Inc. Announces Approval for Trading on OTCQB Venture Market
June 04, 2020 11:00 ET
|
GeoVax, Inc.
ATLANTA, GA, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GeoVax Reports 2020 First Quarter Financial Results and Provides Corporate Update
May 06, 2020 09:00 ET
|
GeoVax, Inc.
Progress on COVID-19 Vaccine Development; Continued Advancements in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, May 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax...
GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development
April 30, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, April 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases...
GeoVax Applauds and Comments on Passage of $2 Trillion CARES Act
March 30, 2020 09:00 ET
|
GeoVax, Inc.
Company Ready to Advance COVID-19 Vaccine Candidates to Animal Efficacy Testing, Manufacturing Scale-Up, and Human Clinical Trials ATLANTA, GA, March 30, 2020 (GLOBE NEWSWIRE) -- via...
GeoVax Reports 2019 Year-End Financial Results And Provides Corporate Update
March 25, 2020 09:00 ET
|
GeoVax, Inc.
Recent Pivot to COVID-19 Vaccine Development;Continued Advancements in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...